Press Releases ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 04/12/2025 GMT			5-day change	1st Jan Change
251.51 ^USD	+0.03%		-1.38%	+9.98%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Press Releases

Major Breakthrough in At Home Sleep Therapy: ResMed Launches "AirCurve 11 VAuto" to Improve Sleep Apnea Treatment Comfort and Compliance	11-28	AQ
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	11-24	PU
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	11-24	PU
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	11-24	PU
ResMed : 1Q26 Earnings Presentation	10-30	PU
ResMed : Earnings Release Q1 2026 PDF	10-30	PU
ResMed: Fiscal Q1 Earnings Snapshot	10-30	AQ
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026	10-30	GL
ResMed AirSense 11 AutoSet Redefines Sleep Apnea Treatment with Intelligent Pressure Adjustment, Cloud Connectivity, and Unmatched Comfort	10-29	AQ
Resmed : Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in Australia	10-26	PU
ResMed's AirSense(TM) 11 CPAP Machines Revolutionize Sleep Apnea Treatment with Advanced Features and Enhanced Comfort	10-13	AQ
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025	10-09	GL
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025	10-09	AQ
Resmed : Showcases Leadership on Innovation, AI, and Patient-Centered Care at AdvaMed MedTech Conference	09-29	PU
The Future of Home Oxygen Therapy - The New Technological Advancements from Everflo and ResMed That Are Changing the Game	09-26	AQ
Resmed : Corporate Overview	09-19	PU
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025	09-16	GL
Resmed : Stewardship Presentation	09-13	PU
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority	09-03	GL
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds	08-27	GL
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds	08-27	AQ
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs	08-21	GL
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs	08-21	AQ
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio	08-18	GL
ResMed : Earnings Webcast FY 2025 Transcript PDF	08-02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed's innovation-driven success and prospects

October 31, 2025 at 08:55 am